ABSTRACT
The population infected with HIV, consequent to the use of antiretroviral (ARV)
medications, is aging. Questions about cardiovascular disease (CVD) in this
population have prompted inquiry (1-4). Cardiovascular events in HIV-positive
individuals are uncommon and occur in the background of CVD in the general
population. These circumstances have contributed to a number of conflicting
findings in this field of study (5-7).
